These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 1718439
41. Transformation and characterization of mutant human fibroblasts defective in peroxisome assembly. Okamoto H, Suzuki Y, Shimozawa N, Yajima S, Masuno M, Orii T. Exp Cell Res; 1992 Aug; 201(2):307-12. PubMed ID: 1639130 [Abstract] [Full Text] [Related]
42. Identification of pristanoyl-CoA oxidase and phytanic acid decarboxylation in peroxisomes and mitochondria from human liver: implications for Zellweger syndrome. Wanders RJ, van Roermund CW, Jakobs C, ten Brink HJ. J Inherit Metab Dis; 1991 Aug; 14(3):349-52. PubMed ID: 1770789 [No Abstract] [Full Text] [Related]
43. Peroxisomes in infantile phytanic acid storage disease: a cytochemical study of skin fibroblasts. Beard ME, Moser AB, Sapirstein V, Holtzman E. J Inherit Metab Dis; 1986 Aug; 9(4):321-34. PubMed ID: 2435984 [Abstract] [Full Text] [Related]
44. Molecular cloning and functional expression of a human peroxisomal acyl-coenzyme A oxidase. Aoyama T, Tsushima K, Souri M, Kamijo T, Suzuki Y, Shimozawa N, Orii T, Hashimoto T. Biochem Biophys Res Commun; 1994 Feb 15; 198(3):1113-8. PubMed ID: 8117268 [Abstract] [Full Text] [Related]
45. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. Moser AB, Rasmussen M, Naidu S, Watkins PA, McGuinness M, Hajra AK, Chen G, Raymond G, Liu A, Gordon D. J Pediatr; 1995 Jul 15; 127(1):13-22. PubMed ID: 7541833 [Abstract] [Full Text] [Related]
46. Functional heterogeneity of C-terminal peroxisome targeting signal 1 in PEX5-defective patients. Shimozawa N, Zhang Z, Suzuki Y, Imamura A, Tsukamoto T, Osumi T, Fujiki Y, Orii T, Barth PG, Wanders RJ, Kondo N. Biochem Biophys Res Commun; 1999 Aug 27; 262(2):504-8. PubMed ID: 10462504 [Abstract] [Full Text] [Related]
47. Significance of catalase in peroxisomal fatty acyl-CoA beta-oxidation. Hashimoto F, Hayashi H. Biochim Biophys Acta; 1987 Sep 04; 921(1):142-50. PubMed ID: 2887206 [Abstract] [Full Text] [Related]
48. Abnormality in catalase import into peroxisomes leads to severe neurological disorder. Sheikh FG, Pahan K, Khan M, Barbosa E, Singh I. Proc Natl Acad Sci U S A; 1998 Mar 17; 95(6):2961-6. PubMed ID: 9501198 [Abstract] [Full Text] [Related]
49. [Neuropathology of peroxisomal disorders; Zellweger syndrome and neonatal adrenoleukodystrophy]. Takashima S, Houdou S, Kamei J, Hasegawa M, Mito T, Suzuki Y, Maeda K. No To Hattatsu; 1992 Mar 17; 24(2):186-93. PubMed ID: 1567656 [Abstract] [Full Text] [Related]
50. Immunochemical analysis of the peroxisomal beta-oxidation enzymes in rat and human heart and skeletal muscle and in skeletal muscle of Zellweger patients. Reubsaet FA, Brückwilder ML, Veerkamp JH, Trijbels JM, Hashimoto T, Monnens LA. Biochem Med Metab Biol; 1991 Apr 17; 45(2):197-203. PubMed ID: 1883627 [Abstract] [Full Text] [Related]
51. Comparative effects of clofibrate on peroxisomal enzymes of human (Hep EBNA2) and rat (FaO) hepatoma cell lines. Scotto C, Keller JM, Schohn H, Dauça M. Eur J Cell Biol; 1995 Apr 17; 66(4):375-81. PubMed ID: 7656903 [Abstract] [Full Text] [Related]
52. How proteins get into microbodies (peroxisomes, glyoxysomes, glycosomes). Borst P. Biochim Biophys Acta; 1986 May 05; 866(4):179-203. PubMed ID: 3516224 [Abstract] [Full Text] [Related]
53. Hepatic peroxisomes in isolated hyperpipecolic acidaemia: evidence supporting its classification as a single peroxisomal enzyme deficiency. Kerckaert I, Poll-The BT, Espeel M, Duran M, Roeleveld AB, Wanders RJ, Roels F. Virchows Arch; 2000 May 05; 436(5):459-65. PubMed ID: 10881739 [Abstract] [Full Text] [Related]
54. Functional expression of rat peroxisomal acyl-CoA oxidase in Spodoptera frugiperda cells. Chu R, Usuda N, Reddy MK, Liu C, Hashimoto T, Alvares K, Rao MS, Reddy JK. Biochem Biophys Res Commun; 1994 Apr 15; 200(1):178-86. PubMed ID: 8166685 [Abstract] [Full Text] [Related]
55. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Nemali MR, Usuda N, Reddy MK, Oyasu K, Hashimoto T, Osumi T, Rao MS, Reddy JK. Cancer Res; 1988 Sep 15; 48(18):5316-24. PubMed ID: 2900680 [Abstract] [Full Text] [Related]
56. Extinction of peroxisomal functions in hepatoma cell-fibroblast hybrids. Bioukar EB, Sarrazin S, Conti M, Rabetafika E, Carreau JP, Dhorne-Pollet S, Raynaud N, Deschatrette J. Biochem Genet; 1996 Apr 15; 34(3-4):77-91. PubMed ID: 8734409 [Abstract] [Full Text] [Related]
57. Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders. Peduto A, Baumgartner MR, Verhoeven NM, Rabier D, Spada M, Nassogne MC, Poll-The BT, Bonetti G, Jakobs C, Saudubray JM. Mol Genet Metab; 2004 Jul 15; 82(3):224-30. PubMed ID: 15234336 [Abstract] [Full Text] [Related]
58. Distinction between peroxisomal bifunctional enzyme and acyl-CoA oxidase deficiencies. Watkins PA, McGuinness MC, Raymond GV, Hicks BA, Sisk JM, Moser AB, Moser HW. Ann Neurol; 1995 Sep 15; 38(3):472-7. PubMed ID: 7668838 [Abstract] [Full Text] [Related]
59. Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients. Mihalik SJ, Moser HW, Watkins PA, Danks DM, Poulos A, Rhead WJ. Pediatr Res; 1989 May 15; 25(5):548-52. PubMed ID: 2717271 [Abstract] [Full Text] [Related]
60. Genetic and biochemical heterogeneity in patients with the rhizomelic form of chondrodysplasia punctata--a complementation study. Heikoop JC, Wanders RJ, Strijland A, Purvis R, Schutgens RB, Tager JM. Hum Genet; 1992 Jun 15; 89(4):439-44. PubMed ID: 1618493 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]